Eduardo Acevedo

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

Christopher J. Hawkey, Loren Laine, Thomas Simon et al. · Arthritis & Rheumatism · 2000 · 365 citations

Medicine, Pharmacology, Pharmacotherapy +13

Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations

Xana Kim-Howard, Celi Sun, Julio E. Molineros et al. · Human Molecular Genetics · 2013 · 86 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus

Elena Sánchez, Ryan Webb, Astrid Rasmussen et al. · Arthritis & Rheumatism · 2010 · 84 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Tolerability profiles of rofecoxib (Vioxx®) and Arthrotec®: A comparison of six weeks treatment in patients with osteoarthritis

Eduardo Acevedo · Scandinavian Journal of Rheumatology · 2001 · 25 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12